Annual D&A
$1.41 M
+$223.40 K+18.77%
December 31, 2023
Summary
- As of February 7, 2025, VNRX annual depreciation & amortization is $1.41 million, with the most recent change of +$223.40 thousand (+18.77%) on December 31, 2023.
- During the last 3 years, VNRX annual D&A has risen by +$371.90 thousand (+35.71%).
- VNRX annual D&A is now at all-time high.
Performance
VNRX Depreciation And Amortization Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
Quarterly D&A
$341.30 K
+$17.80 K+5.50%
September 30, 2024
Summary
- As of February 7, 2025, VNRX quarterly depreciation & amortization is $341.30 thousand, with the most recent change of +$17.80 thousand (+5.50%) on September 30, 2024.
- Over the past year, VNRX quarterly D&A has dropped by -$22.00 thousand (-6.06%).
- VNRX quarterly D&A is now -6.06% below its all-time high of $363.30 thousand, reached on December 31, 2023.
Performance
VNRX Quarterly D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
TTM D&A
$1.35 M
-$21.20 K-1.55%
September 30, 2024
Summary
- As of February 7, 2025, VNRX TTM depreciation & amortization is $1.35 million, with the most recent change of -$21.20 thousand (-1.55%) on September 30, 2024.
- Over the past year, VNRX TTM D&A has dropped by -$63.10 thousand (-4.46%).
- VNRX TTM D&A is now -4.46% below its all-time high of $1.41 million, reached on December 31, 2023.
Performance
VNRX TTM D&A Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Related metrics
VNRX Depreciation And Amortization Trends
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | +18.8% | -6.1% | -4.5% |
3 y3 years | +35.7% | +19.4% | +14.6% |
5 y5 years | +122.1% | +45.4% | +27.2% |
VNRX Depreciation And Amortization Highs & Lows
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3-year | at high | +23.4% | -6.1% | +18.3% | -4.5% | +17.9% |
5 y | 5-year | at high | +56.6% | -6.1% | +45.4% | -4.5% | +49.6% |
alltime | all time | at high | +1091.7% | -6.1% | +1004.5% | -4.5% | +3991.5% |
VolitionRx Limited Depreciation And Amortization History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sep 2024 | - | $341.30 K(+5.5%) | $1.35 M(-1.5%) |
Jun 2024 | - | $323.50 K(+0.4%) | $1.37 M(-2.1%) |
Mar 2024 | - | $322.10 K(-11.3%) | $1.40 M(-0.9%) |
Dec 2023 | $1.41 M(+18.8%) | $363.30 K(+0.2%) | $1.41 M(+4.0%) |
Sep 2023 | - | $362.50 K(+2.7%) | $1.36 M(+5.0%) |
Jun 2023 | - | $352.90 K(+5.5%) | $1.29 M(+4.8%) |
Mar 2023 | - | $334.60 K(+8.1%) | $1.23 M(+3.8%) |
Dec 2022 | $1.19 M(+3.9%) | $309.40 K(+4.0%) | $1.19 M(+1.8%) |
Sep 2022 | - | $297.60 K(+1.5%) | $1.17 M(+1.0%) |
Jun 2022 | - | $293.30 K(+1.2%) | $1.16 M(-0.0%) |
Mar 2022 | - | $289.70 K(+0.4%) | $1.16 M(+1.1%) |
Dec 2021 | $1.15 M(+10.0%) | $288.60 K(+1.0%) | $1.15 M(-2.8%) |
Sep 2021 | - | $285.80 K(-2.6%) | $1.18 M(+4.5%) |
Jun 2021 | - | $293.40 K(+5.8%) | $1.13 M(+4.8%) |
Mar 2021 | - | $277.40 K(-13.7%) | $1.08 M(+3.3%) |
Dec 2020 | $1.04 M(+15.4%) | $321.50 K(+36.9%) | $1.04 M(-1.9%) |
Sep 2020 | - | $234.80 K(-2.9%) | $1.06 M(+3.9%) |
Jun 2020 | - | $241.90 K(-0.5%) | $1.02 M(+5.8%) |
Mar 2020 | - | $243.20 K(-28.8%) | $965.80 K(+7.0%) |
Dec 2019 | $902.40 K(+41.8%) | $341.60 K(+75.3%) | $902.40 K(+24.9%) |
Sep 2019 | - | $194.90 K(+4.7%) | $722.60 K(+5.6%) |
Jun 2019 | - | $186.10 K(+3.5%) | $684.30 K(+3.7%) |
Mar 2019 | - | $179.80 K(+11.1%) | $659.80 K(+3.7%) |
Dec 2018 | $636.40 K | $161.80 K(+3.3%) | $636.40 K(+0.8%) |
Sep 2018 | - | $156.60 K(-3.1%) | $631.40 K(+1.8%) |
Jun 2018 | - | $161.60 K(+3.3%) | $620.40 K(+4.9%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2018 | - | $156.40 K(-0.3%) | $591.30 K(+11.9%) |
Dec 2017 | $528.20 K(+70.7%) | $156.80 K(+7.7%) | $528.20 K(+17.3%) |
Sep 2017 | - | $145.60 K(+9.9%) | $450.20 K(+17.4%) |
Jun 2017 | - | $132.50 K(+42.0%) | $383.40 K(+16.0%) |
Mar 2017 | - | $93.30 K(+18.4%) | $330.40 K(+6.8%) |
Dec 2016 | $309.40 K(+30.9%) | $78.80 K(0.0%) | $309.30 K(+2.2%) |
Sep 2016 | - | $78.80 K(-0.9%) | $302.50 K(+2.0%) |
Jun 2016 | - | $79.50 K(+10.1%) | $296.60 K(+10.5%) |
Mar 2016 | - | $72.20 K(+0.3%) | $268.40 K(+13.5%) |
Dec 2015 | $236.30 K(+66.3%) | $72.00 K(-1.2%) | $236.40 K(+14.4%) |
Sep 2015 | - | $72.90 K(+42.1%) | $206.60 K(+21.5%) |
Jun 2015 | - | $51.30 K(+27.6%) | $170.00 K(+12.3%) |
Mar 2015 | - | $40.20 K(-4.7%) | $151.40 K(+6.5%) |
Dec 2014 | $142.10 K(-2.9%) | $42.20 K(+16.3%) | $142.10 K(+3.5%) |
Sep 2014 | - | $36.30 K(+11.0%) | $137.30 K(-0.1%) |
Jun 2014 | - | $32.70 K(+5.8%) | $137.50 K(-2.4%) |
Mar 2014 | - | $30.90 K(-17.4%) | $140.90 K(-3.8%) |
Dec 2013 | $146.40 K(+7.9%) | $37.40 K(+2.5%) | $146.40 K(+3.6%) |
Sep 2013 | - | $36.50 K(+1.1%) | $141.30 K(+2.0%) |
Jun 2013 | - | $36.10 K(-0.8%) | $138.50 K(-0.5%) |
Mar 2013 | - | $36.40 K(+12.7%) | $139.20 K(+2.5%) |
Dec 2012 | $135.70 K(+14.4%) | $32.30 K(-4.2%) | $135.80 K(+31.2%) |
Sep 2012 | - | $33.70 K(-8.4%) | $103.50 K(+48.3%) |
Jun 2012 | - | $36.80 K(+11.5%) | $69.80 K(+111.5%) |
Mar 2012 | - | $33.00 K | $33.00 K |
Dec 2011 | $118.60 K | - | - |
FAQ
- What is VolitionRx Limited annual depreciation & amortization?
- What is the all time high annual D&A for VolitionRx Limited?
- What is VolitionRx Limited annual D&A year-on-year change?
- What is VolitionRx Limited quarterly depreciation & amortization?
- What is the all time high quarterly D&A for VolitionRx Limited?
- What is VolitionRx Limited quarterly D&A year-on-year change?
- What is VolitionRx Limited TTM depreciation & amortization?
- What is the all time high TTM D&A for VolitionRx Limited?
- What is VolitionRx Limited TTM D&A year-on-year change?
What is VolitionRx Limited annual depreciation & amortization?
The current annual D&A of VNRX is $1.41 M
What is the all time high annual D&A for VolitionRx Limited?
VolitionRx Limited all-time high annual depreciation & amortization is $1.41 M
What is VolitionRx Limited annual D&A year-on-year change?
Over the past year, VNRX annual depreciation & amortization has changed by +$223.40 K (+18.77%)
What is VolitionRx Limited quarterly depreciation & amortization?
The current quarterly D&A of VNRX is $341.30 K
What is the all time high quarterly D&A for VolitionRx Limited?
VolitionRx Limited all-time high quarterly depreciation & amortization is $363.30 K
What is VolitionRx Limited quarterly D&A year-on-year change?
Over the past year, VNRX quarterly depreciation & amortization has changed by -$22.00 K (-6.06%)
What is VolitionRx Limited TTM depreciation & amortization?
The current TTM D&A of VNRX is $1.35 M
What is the all time high TTM D&A for VolitionRx Limited?
VolitionRx Limited all-time high TTM depreciation & amortization is $1.41 M
What is VolitionRx Limited TTM D&A year-on-year change?
Over the past year, VNRX TTM depreciation & amortization has changed by -$63.10 K (-4.46%)